Dystroglycan in skin and cutaneous cells: β-Subunit is from the cell surface

Journal of Investigative Dermatology

Volumn 122, Issue 6, 2004, Pages 1372-1380

  Herzog, Christine ^a   Has, Cristina ^b   Franzke, Claus Werner ^b   Echtermeyer, Frank G ^a   Schlötzer Schrehardt, Ursula ^c   Kröger, Stephan ^d   Gustafsson, Erika ^e   Fässler, Reinhard ^f   Bruckner Tuderman, Leena ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e LUND UNIVERSITY   (Sweden)

^f MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Adhesion; BM; Glycoprotein; Secretase; Shedding

Indexed keywords

DYSTROGLYCAN; INTERLEUKIN 1BETA; LIGAND; METALLOPROTEINASE INHIBITOR; PERLECAN; PHORBOL ESTER DERIVATIVE;

ALPHA CHAIN; ARTICLE; BASAL CELL; BETA CHAIN; BIOSYNTHESIS; CELL SECRETION; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; EPIDERMIS; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; SKIN CELL;

EID: 2942568034     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22605.x     Document Type: Article

References (45)

1. Airola K, Ahonen M, Johansson N, Heikkila P, Kere J, Kahari VM, Saarialho-Kere UK: Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J Histochem Cytochem 46:437-447, 1998
2. Amour A, Knight CG, Webster A, et al: The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 473:275-279, 2000
3. Andac Z, Sasaki T, Mann K, Brancaccio A, Deutzmann R, Timpl R: Analysis of heparin, alpha-dystroglycan and sulfatide binding to the G domain of the laminin alphal chain by site-directed mutagenesis. J Mol Biol 287: 253-264, 1999
4. Armstrong SC, Latham CA, Ganote CE: An ischemic beta-dystroglycan (betaDG) degradation product: Correlation with irreversible injury in adult rabbit cardiomyocytes. Mol Cell Biochem 242:71-79, 2003
5. Borland G, Murphy G, Ager A: Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes. J Biol Chem 274:2810-2815, 1999
6. Brockington M, Blake DJ, Prandini P, et al: Mutations in thefukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 69:1198-1209, 2001
7. Costell M, Gustafsson E, Aszodi A, et al: Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122, 1999
8. Cote PD, Moukhles H, Carbonetto S: Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution. J Biol Chem 277:4672-4679, 2002
9. De Block M, Debrouwer D: RNA-RNA in situ hybridization using digoxigenin-labeled probes: The use of high-molecular-weight polyvinyl alcohol in the alkaline phosphatase indoxyl-nitroblue tetrazolium reaction. Anal Biochem 215:86-89, 1993
10. Durbeej M, Campbell KP: Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem 274:26609-26616, 1999
11. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P: Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 46:449-457, 1998
12. Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M: Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 148:811-824, 2000
13. Flannery CR, Little CB, Caterson B, Hughes CE: Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes. Matrix Biol 18:225-237, 1999
14. Franzke CW, Tasanen K, Schacke H, et al: Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J 21:5026-5035, 2002
15. Gagnoux-Palacios L, Allegra M, Spirito F, Pommeret O, Romero C, Ortonne JP, Meneguzzi G: The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol 153:835-850, 2001
16. Gorecki DC, Derry JM, Barnard EA: Dystroglycan: Brain localisation and chromosome mapping in the mouse. Hum Mol Genet 3:1589-1597, 1994
17. Hemler ME: Dystroglycan versatility. Cell 97:543-546, 1999
18. Henry MD, Campbell KP: Dystroglycan inside and out. Curr Opin Cell Biol 11:602-607, 1999
19. Henry MD, Cohen MB, Campbell KP: Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 32:791-795, 2001
20. Herrmann R, Straub V, Blank M, et al: Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 9:2335-2340, 2000
21. Holt KH, Crosbie RH, Venzke DP, Campbell KP: Biosynthesis of dystroglycan: Processing of a precursor propeptide. FEBS Lett 468:79-83, 2000
22. Hooper NM, Karran EH, Turner AJ: Membrane protein secretases. Biochem J 321 (Part 2):265-279, 1997
23. Hosokawa H, Ninomiya H, Kitamura Y, Fujiwara K, Masaki T: Vascular endothelial cells that express dystroglycan are involved in angiogenesis. J Cell Sci 115:1487-1496, 2002
24. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702, 1992
25. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepnick K, Francke U, Campbell KP: Human dystroglycan: Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 2:1651-1657, 1993
26. Kano H, Kobayashi K, Herrmann R, et al: Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 291: 1283-1286, 2002
27. Losasso C, Di Tommaso F, Sgambato A, et al: Anomalous dystroglycan in carcinoma cell lines. FEBS Lett 484:194-198, 2000
28. Meier T, Ruegg MA: The role of dystroglycan and its ligands in physiology and disease. News Physiol Sci 15:255-259, 2000
29. Merlos-Suarez A, Fernandez-Larrea J, Reddy P, Baselga J, Arribas J: Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. J Biol Chem 273:24955-24962, 1998
30. Michele DE, Campbell KP: Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J Biol Chem 278:15457-15460, 2003
31. Moss ML, Jin SL, Milla ME, et al: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736, 1997
32. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ: A role for dystroglycan in epithelial polarization: Loss of function in breast tumor cells. Cancer Res 6:7102-7109, 2002
33. Peschon JJ, Slack JL, Reddy P, et al: An essential role for ectodomain shedding in mammalian development. Science 282:1281-1284, 1998
34. Rattenholl A, Pappano WN, Koch M, et al: Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J Biol Chem 277:26372-26378, 2002
35. Saito F, Masaki T, Kamakura K, et al: Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells. J Biol Chem 274:8240-8246, 1999
36. Schacke H, Schumann H, Hammami-Hauasli N, Raghunath M, Bruckner-Tuderman L: Two forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomain. J Biol Chem 273:25937-25943, 1998
37. Schumann H, Baetge J, Tasanen K, Wojnarowska F, Schacke H, Zillikens D, Bruckner-Tuderman L: The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 156:685-695, 2000
38. Sciandra F, Schneider M, Giardina B, Baumgartner S, Petrucci TC, Brancaccio A: Identification of the β-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan. Eur J Biochem 268:4590-4597, 2001
39. Shimizu H, Hosokawa H, Ninomiya H, Miner JH, Masaki T: Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan. J Biol Chem 274:11995-12000, 1999
40. Talts JF, Andac Z, Gohring W, Brancaccio A, Timpl R: Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J 18:863-870, 1999
41. Tasanen K, Eble JA, Aumailley M, et al: Collagen XVII is destabilized by a glycine substitution mutation in the cell adhesion domain Col15. J Biol Chem 275:3093-3099, 2000
42. Toullec D, Pianetti P, Coste H, et al: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781, 1991
43. Tunggal L, Ravaux J, Pesch M, et al: Defective laminin 5 processing in cylindroma cells. Am J Pathol 160:459-468, 2002
44. Veitch DP, Nokelainen P, McGowan KA, et al: Mammalian Tolloid metalloproteinase, and not matrix metalloprotease 2 nor membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem 278:15661-15668, 2003
45. Yamada H, Saito F, Fukuta-Ohi H, et al: Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 10:1563-1569, 2001